Study: Small interfering RNAs hold promise for Ebola virus

05/28/2010 | Reuters

Administering daily injections of small interfering RNAs for a week was effective in treating four rhesus monkeys that were given high doses of the Ebola virus, according to researchers for the U.S. government and Tekmira Pharmaceuticals. They found that siRNAs control the activity of the virus while waiting for the immune system to take over. The researchers plan to apply for federal financing to further test the technique.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN